Basit öğe kaydını göster

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer

dc.contributor.authorDilege, Sukru
dc.contributor.authorSakallioglu, Barkin
dc.contributor.authorTopuz, Erkan
dc.contributor.authorSaglam, Esra Kaytan
dc.contributor.authorKizir, AHMET
dc.contributor.authorOral, Ethem Nezih
dc.contributor.authorSaip, Pinar
dc.contributor.authorToker, Alper
dc.contributor.authorSen, Fatma
dc.contributor.authorAydiner, Adnan
dc.date.accessioned2021-03-03T11:05:38Z
dc.date.available2021-03-03T11:05:38Z
dc.date.issued2011
dc.identifier.citationSen F., Saglam E. K. , Toker A., Dilege S., Kizir A., Oral E. N. , Saip P., Sakallioglu B., Topuz E., Aydiner A., "Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.68, sa.6, ss.1497-1505, 2011
dc.identifier.issn0344-5704
dc.identifier.othervv_1032021
dc.identifier.otherav_260e364a-1ff0-4425-b692-33e8cc05fa6a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/30473
dc.identifier.urihttps://doi.org/10.1007/s00280-011-1642-8
dc.description.abstractThe aim of this study was to evaluate efficacy and feasibility of a combination of weekly docetaxel and cisplatin administered concomitantly with radiotherapy followed by surgery in addition to consolidation chemotherapy with docetaxel and cisplatin administered every 3 weeks in stage III non-small cell lung cancer (NSCLC).
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleWeekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer
dc.typeMakale
dc.relation.journalCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume68
dc.identifier.issue6
dc.identifier.startpage1497
dc.identifier.endpage1505
dc.contributor.firstauthorID21243


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster